Patent · US Active

Type V CRISPR-Cas systems and use thereof

US11639523B2 · kind B2 · utility

0Cited by
4References
14Claims
0Family size

Assignees

Inventors

Key dates

Filing dateJun 5, 2020
Grant dateMay 2, 2023
Priority date
Expiry dateJun 5, 2040

Classification

  • Technology area (CPC G)Physics
  • CPC primaryG01N2333/165
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Engineered or non-naturally occurring systems and compositions comprising a novel Cas12b and a guide molecule. Also provided include methods of use the systems and compositions, including in treating and diagnosing diseases.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.